Madrid, Spain

Miguel Vega García

This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignee: Allinky Biopharma. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Miguel Vega García. Retrieved from https://idiyas.com/inventor/miguel-vega-garcía

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Miguel Vega García: Innovator in Medicinal Chemistry

Introduction

Miguel Vega García is a prominent inventor based in Madrid, Spain. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on tetrahydroisoquinoline compounds. His research focuses on developing new compounds that can be utilized in the treatment of cancer.

Latest Patents

Miguel holds a patent for a novel class of tetrahydroisoquinoline compounds. The patent details a unique formula that can be used in various compositions aimed at treating cancer. This invention represents a significant advancement in the search for effective cancer therapies.

Career Highlights

Miguel is currently associated with Allinky Biopharma, where he applies his expertise in medicinal chemistry to develop new therapeutic solutions. His work has garnered attention in the scientific community, highlighting his role as an innovator in the pharmaceutical industry.

Collaborations

Miguel collaborates with talented professionals in his field, including Pedro Manuel Campos Muelas and Esther Carrasco Romero. These partnerships enhance the research and development efforts at Allinky Biopharma, fostering an environment of innovation.

Conclusion

Miguel Vega García is a dedicated inventor whose work in tetrahydroisoquinoline compounds holds promise for cancer treatment. His contributions to medicinal chemistry continue to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…